Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (761-770 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|May 15, 2003
PRAC2: a new gene expressed in human prostate and prostate cancerPär Olsson, Akira Motegi, Tapan K Bera, et al.
The Prostate|May 15, 2003
ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002Niels Tørring, Frederik Dagnaes-Hansen, Boe Sandahl Sørensen, et al.
The Prostate|May 15, 2003
Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen statusJesus M Torres, Estrella Ruiz, Esperanza Ortega
The Prostate|March 18, 2003
Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zonesHerbert Augustin, Andreas Erbersdobler, Markus Graefen, et al.
The Prostate|July 15, 2003
Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3Shalini Murthy, Marco Marcelli, Nancy L Weigel
The Prostate|July 15, 2003
Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancerMasahiro Yashi, Akinori Nukui, Shinsuke Kurokawa, et al.
The Prostate|May 29, 2003
Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivoA H Fortier, J W Holaday, H Liang, et al.
The Prostate|April 25, 2012
Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopesLaura E Johnson, Douglas G McNeel
The Prostate|April 28, 2012
Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agentHsiang-Yu Lin, Yi-Chiu Kuo, Yu-I Weng, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Pageof 609

Showing results (761-770 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|May 15, 2003
PRAC2: a new gene expressed in human prostate and prostate cancerPär Olsson, Akira Motegi, Tapan K Bera, et al.
The Prostate|May 15, 2003
ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002Niels Tørring, Frederik Dagnaes-Hansen, Boe Sandahl Sørensen, et al.
The Prostate|May 15, 2003
Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen statusJesus M Torres, Estrella Ruiz, Esperanza Ortega
The Prostate|March 18, 2003
Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zonesHerbert Augustin, Andreas Erbersdobler, Markus Graefen, et al.
The Prostate|July 15, 2003
Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3Shalini Murthy, Marco Marcelli, Nancy L Weigel
The Prostate|July 15, 2003
Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancerMasahiro Yashi, Akinori Nukui, Shinsuke Kurokawa, et al.
The Prostate|May 29, 2003
Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivoA H Fortier, J W Holaday, H Liang, et al.
The Prostate|April 25, 2012
Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopesLaura E Johnson, Douglas G McNeel
The Prostate|April 28, 2012
Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agentHsiang-Yu Lin, Yi-Chiu Kuo, Yu-I Weng, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Pageof 609